Clinical Trials Logo

Filter by:
NCT ID: NCT05341076 Not yet recruiting - Dystocia Clinical Trials

Labor Scale Versus WHO Partograph for Management of Labor (ScaLP)

ScaLP
Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The current study aims at evaluating the impact of the implementation of the labor scale, in comparison to the standard WHO partograph, in the management of primiparous women, including CD rate, maternal and neonatal outcomes of labor.

NCT ID: NCT05341284 Not yet recruiting - HPV Infection Clinical Trials

Impact of HPV Vaccination on HPV Infection and Cervical Related Disease Burden in Real-World Settings (HPV-RWS)

HPV-RWS
Start date: August 1, 2022
Phase:
Study type: Observational

Take AS04 adjuvanted HPV16/18 vaccine as an example to evaluate the impact of HPV vaccination on HPV infection and related disease burden in the real world based on prospective cohort and Yinzhou Regional Health Information Platform (YRHIP), in order to bridge the gap in relevant evidence in China.

NCT ID: NCT05368727 Not yet recruiting - Clinical trials for Bladder Outlet Obstruction

Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction (LUTO)

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to study the outcomes of maternal and fetal patients who are undergoing fetal intervention for severe isolated lower urinary tract obstruction (LUTO) at University of Miami/Jackson Health System.

NCT ID: NCT05373667 Not yet recruiting - Pelvic Pain Clinical Trials

A Prospective Clinical Study to Assess the Spinal Cord Stimulation System in the Treatment of Chronic Pelvic Pain

SCS/CPP
Start date: August 1, 2022
Phase:
Study type: Observational

Prospective observational assessment of the efficacy of Spinal Cord Stimulation (SCS) treatment in patients with neuropathic pelvic pain.

NCT ID: NCT05378867 Not yet recruiting - Clinical trials for Metastatic Colorectal Cancer (CRC)

A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC

CRC
Start date: August 1, 2022
Phase: Phase 3
Study type: Interventional

This is a Phase 3, multicenter, randomized and double-blind study assessing the interchangeability between TRS003 and China-approved Bevacizumab® (also called China-approved Avastin) for first-line treatment of patients with metastatic Colorectal Cancer (CRC), approximately 126 patients will be enrolled in this study. Patients who sign the informed consent, meet the eligibility criteria and are confirmed as non-progressors after lead-in treatment period with Bevacizumab® in combination with modified FOLFOX6 chemotherapy for 6 cycles, will be randomized (1:1) to either the non-switching arm and receive Bevacizumab® + modified FOLFOX6 for all subsequent cycles or to the switching arm and receive TRS003 alternating with Bevacizumab® in combination with mFOLFOX6 until disease progression or intolerability.

NCT ID: NCT05381805 Not yet recruiting - Atrial Fibrillation Clinical Trials

ISOLATION 2.0: a Multicenter Clinical Care and Research Platform

Start date: August 1, 2022
Phase:
Study type: Observational

Treatment recommendations and guidelines for patients with atrial fibrillation (AF) are continuously changing. The role of catheter ablation in the treatment of AF increases and the techniques of the procedures are improving unceasingly. Responding to and evaluating the effect of these changes requires careful examination of this patient population and procedure outcomes. The aim is to create a clinical characterization platform for patients scheduled for AF ablations with the purpose to optimize health care processes and related translational research.

NCT ID: NCT05382832 Not yet recruiting - Migraine Clinical Trials

Botox Vs Spinal Cord Stimulation in the Treatment of Refractory Migraine Clinical Trial

BTX/SCS/TMig
Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The clinical trial is focused on the treatment of selected patients with a migraine after implantation of spinal cord stimulator (SCS) based on previous neurological examination. Patients will be randomized and divided into two groups. According to randomization patients will receive saline or botox into the epidural space. The efficacy of treatment will be compared and estimated in both groups during different SCS settings. Data will be collected in pre-set time frames.

NCT ID: NCT05390203 Not yet recruiting - Sexual Dysfunction Clinical Trials

Sexual Function Before and After Bariatric Surgeries.

Start date: August 1, 2022
Phase:
Study type: Observational

To assess sexual function before and the impact of weight loss after bariatric surgery among obese men with sexual dysfunction.

NCT ID: NCT05394181 Not yet recruiting - Clinical trials for Coronary Artery Disease

Notify 2: An Evaluation of the Impact of Notification of Incidental Coronary Artery Calcium on Statin Rates

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The primary objective is to estimate the impact of notification of primary care provider and patient of at least moderate incidental coronary artery calcification (CAC) on a prior non-gated chest CT on statin prescription rates at 4 months among patients without a clinical history of atherosclerotic cardiovascular disease not actively on statin therapy. This study will determine if notifying patients and their primary care clinician about an existing finding will influence shared decision-making around statins between patients and their primary care clinician.

NCT ID: NCT05399017 Not yet recruiting - Respiratory Failure Clinical Trials

Clinical Evaluation of EZVent in Hospitalized Mechanically Ventilated Patients

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

Investigation Device: EZVent Ventilator System is designed for respiratory support in hospitalized mechanical ventilated patients. The Ventilator is designed to be used for adults patients. It is designed to be a stationary product suitable for service in hospitals, critical care situations to provide continuous positive pressure respiratory support to the patient. The ventilator met EDA, ISO 80601-2-12 requirements on essential performance of critical care ventilator and other applicable international standards. Study Title: Open-labeled, non-randomized, self-controlled study to evaluate the safety and performance of EZVent in hospitalized mechanically ventilated patients. Investigational Device EZVent Ventilator System. Purpose: Evaluation of the safety and performance of EZVent in hospitalized mechanically ventilated patients. Objectives: Evaluation of the safety and performance of EZVent through monitoring the vital signs and arterial blood gases (ABG) in comparison to a commercial ventilator.